This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butkiewicz, N.
Right arrow Articles by Hong, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butkiewicz, N.
Right arrow Articles by Hong, Z.

 Previous Article  |  Next Article 

Journal of Virology, May 2000, p. 4291-4301, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3

Nancy Butkiewicz,1 Nanhua Yao,2 Weidong Zhong,1 Jacquelyn Wright-Minogue,1 Paul Ingravallo,1 Rumin Zhang,2 James Durkin,2 David N. Standring,1 Bahige M. Baroudy,1 David V. Sangar,3 Stanley M. Lemon,3 Johnson Y. N. Lau,1 and Zhi Hong1,*

Departments of Antiviral Therapy1 and Structural Chemistry,2 Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, and Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, Galveston, Texas 77555-10193

Received 22 November 1999/Accepted 22 January 2000

GB virus B (GBV-B) is closely related to hepatitis C virus (HCV) and causes acute hepatitis in tamarins (Saguinus species), making it an attractive surrogate virus for in vivo testing of anti-HCV inhibitors in a small monkey model. It has been reported that the nonstructural protein 3 (NS3) serine protease of GBV-B shares similar substrate specificity with its counterpart in HCV. Authentic proteolytic processing of the HCV polyprotein junctions (NS4A/4B, NS4B/5A, and NS5A/5B) can be accomplished by the GBV-B NS3 protease in an HCV NS4A cofactor-independent fashion. We further characterized the protease activity of a full-length GBV-B NS3 protein and its cofactor requirement using in vitro-translated GBV-B substrates. Cleavages at the NS4A/4B and NS5A/5B junctions were readily detectable only in the presence of a cofactor peptide derived from the central region of GBV-B NS4A. Interestingly, the GBV-B substrates could also be cleaved by the HCV NS3 protease in an HCV NS4A cofactor-dependent manner, supporting the notion that HCV and GBV-B share similar NS3 protease specificity while retaining a virus-specific cofactor requirement. This finding of a strict virus-specific cofactor requirement is consistent with the lack of sequence homology in the NS4A cofactor regions of HCV and GBV-B. The minimum cofactor region that supported GBV-B protease activity was mapped to a central region of GBV-B NS4A (between amino acids Phe22 and Val36) which overlapped with the cofactor region of HCV. Alanine substitution analysis demonstrated that two amino acids, Val27 and Trp31, were essential for the cofactor activity, a finding reminiscent of the two critical residues in the HCV NS4A cofactor, Ile25 and Ile29. A model for the GBV-B NS3 protease domain and NS4A cofactor complex revealed that GBV-B might have developed a similar structural strategy in the activation and regulation of its NS3 protease activity. Finally, a chimeric HCV/GBV-B bifunctional NS3, consisting of an N-terminal HCV protease domain and a C-terminal GBV-B RNA helicase domain, was engineered. Both enzymatic activities were retained by the chimeric protein, which could lead to the development of a chimeric GBV-B virus that depends on HCV protease function.


* Corresponding author. Mailing address: Antiviral Therapy, K-15-4/4945, Schering-Plough Research Institute, 2015 Galloping Hill Rd., Kenilworth, NJ 07033-0539. Phone: (908) 740-3152. Fax: (908) 740-3918. E-mail: zhi.hong{at}spcorp.com.


Journal of Virology, May 2000, p. 4291-4301, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Woollard, D. J., Haqshenas, G., Dong, X., Pratt, B. F., Kent, S. J., Gowans, E. J. (2008). Virus-Specific T-Cell Immunity Correlates with Control of GB Virus B Infection in Marmosets. J. Virol. 82: 3054-3060 [Abstract] [Full Text]  
  • Chen, Z., Benureau, Y., Rijnbrand, R., Yi, J., Wang, T., Warter, L., Lanford, R. E., Weinman, S. A., Lemon, S. M., Martin, A., Li, K. (2007). GB Virus B Disrupts RIG-I Signaling by NS3/4A-Mediated Cleavage of the Adaptor Protein MAVS. J. Virol. 81: 964-976 [Abstract] [Full Text]  
  • Pastorino, B. A. M., Peyrefitte, C. N., Grandadam, M., Thill, M. C. E., Tolou, H. J., Bessaud, M. (2006). Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B-NS3 protease activation.. J. Gen. Virol. 87: 3279-3283 [Abstract] [Full Text]  
  • Niyomrattanakit, P., Winoyanuwattikun, P., Chanprapaph, S., Angsuthanasombat, C., Panyim, S., Katzenmeier, G. (2004). Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation. J. Virol. 78: 13708-13716 [Abstract] [Full Text]  
  • Nam, J.-H., Faulk, K., Engle, R. E., Govindarajan, S., St. Claire, M., Bukh, J. (2004). In Vivo Analysis of the 3' Untranslated Region of GB Virus B after In Vitro Mutagenesis of an Infectious cDNA Clone: Persistent Infection in a Transfected Tamarin. J. Virol. 78: 9389-9399 [Abstract] [Full Text]  
  • Ghibaudo, D., Cohen, L., Penin, F., Martin, A. (2004). Characterization of GB Virus B Polyprotein Processing Reveals the Existence of a Novel 13-kDa Protein with Partial Homology to Hepatitis C Virus p7 Protein. J. Biol. Chem. 279: 24965-24975 [Abstract] [Full Text]  
  • Bright, H., Carroll, A. R., Watts, P. A., Fenton, R. J. (2004). Development of a GB Virus B Marmoset Model and Its Validation with a Novel Series of Hepatitis C Virus NS3 Protease Inhibitors. J. Virol. 78: 2062-2071 [Abstract] [Full Text]  
  • De Tomassi, A., Pizzuti, M., Traboni, C. (2003). Hep3B Human Hepatoma Cells Support Replication of the Wild-Type and a 5'-End Deletion Mutant GB Virus B Replicon. J. Virol. 77: 11875-11881 [Abstract] [Full Text]  
  • Martin, A., Bodola, F., Sangar, D. V., Goettge, K., Popov, V., Rijnbrand, R., Lanford, R. E., Lemon, S. M. (2003). Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc. Natl. Acad. Sci. USA 100: 9962-9967 [Abstract] [Full Text]  
  • De Tomassi, A., Pizzuti, M., Graziani, R., Sbardellati, A., Altamura, S., Paonessa, G., Traboni, C. (2002). Cell Clones Selected from the Huh7 Human Hepatoma Cell Line Support Efficient Replication of a Subgenomic GB Virus B Replicon. J. Virol. 76: 7736-7746 [Abstract] [Full Text]  
  • Sbardellati, A., Scarselli, E., Verschoor, E., De Tomassi, A., Lazzaro, D., Traboni, C. (2001). Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J. Gen. Virol. 82: 2437-2448 [Abstract] [Full Text]  
  • Lanford, R. E., Chavez, D., Guerra, B., Lau, J. Y. N., Hong, Z., Brasky, K. M., Beames, B. (2001). Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes. J. Virol. 75: 8074-8081 [Abstract] [Full Text]  
  • Beames, B., Chavez, D., Guerra, B., Notvall, L., Brasky, K. M., Lanford, R. E. (2000). Development of a Primary Tamarin Hepatocyte Culture System for GB Virus-B: a Surrogate Model for Hepatitis C Virus. J. Virol. 74: 11764-11772 [Abstract] [Full Text]  
  • Sbardellati, A., Scarselli, E., Amati, V., Falcinelli, S., Kekulé, A. S., Traboni, C. (2000). Processing of GB virus B non-structural proteins in cultured cells requires both NS3 protease and NS4A cofactor. J. Gen. Virol. 81: 2183-2188 [Abstract] [Full Text]